There is a trend of rethinking various aspects of clinical research and healthcare. This reevaluation appears to be happening across multiple fields, including cancer, neurodegenerative diseases, endometriosis, and heart failure, with some outlets discussing new approaches to trial design and data collection. The scope of this rethinking is broad, with some discussions also touching on the use of AI, orphan drugs, and disability-focused studies.